Amicus Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
Get Alerts FOLD Hot Sheet
Join SI Premium – FREE
PHILADELPHIA, June 08, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Wednesday, June 15, 2022 at 11:20 a.m. P.T.
A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.
CONTACT:
Investors:Amicus TherapeuticsAndrew FaughnanExecutive Director, Investor Relations[email protected] (609) 662-3809
Media:Amicus TherapeuticsDiana MooreHead of Global Corporate Communications[email protected] (609) 662-5079
FOLD–G
Source: Amicus Therapeutics, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wendel: Availability of the 2023 Universal Registration Document
- Meriwest Credit Union Becomes Official Credit Union Partner of Bay FC
- ROSEN, SKILLED INVESTOR COUNSEL, Encourages World Acceptance Corporation Investors to Inquire About Securities Class Action Investigation – WRLD
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Goldman Sachs, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!